Saphenous Vein Graft Patency: Clinical Trials

2 trials for Saphenous Vein Graft Patency, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Saphenous Vein Graft Patency: new trials by email Literature Review of Saphenous Vein Graft Patency trials Research Report on Saphenous Vein Graft Patency

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of Bidirectional Palpation Test and Transit Time Flow Measurement for LIMA-LAD Graft Patency
Coronary Arterial Disease (CAD), Coronary Artery Bypass
CompletedAbdulgani Orhun YENİGÜN1162023-08-312025-07-08
Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets
Rivaroxaban - Coronary Artery Disease, Saphenous Vein Graft Patency
Phase 3UnknownUnidade Local de Saúde de Coimbra, EPE1002018-12-012018-07-30

Narrower conditions

Coronary Artery Disease (1)  ·  Coronary Stenosis (1)  ·  Leukocyte adhesion deficiency type 1 (1)

Broader conditions

Cardiovascular Diseases (2)  ·  Coronary Disease (2)  ·  Heart Diseases (2)  ·  Myocardial Ischemia (2)  ·  Vascular Diseases (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)

Interventions

Rivaroxaban (1)

Sponsors

Abdulgani Orhun YENİGÜN (1)  ·  Unidade Local de Saúde de Coimbra, EPE (1)

Countries

Portugal (1)  ·  Turkey (Türkiye) (1)